WikiPeptidiaSearch
Research Purposes Only — All information on this page is intended strictly for scientific and educational research purposes. Content including compound descriptions, dosing data, protocols, and mechanistic overviews is derived from publicly available literature and is provided solely to support the research community. Nothing here constitutes medical advice, a clinical recommendation, or an endorsement of any substance for human use. Compounds described may be restricted in certain jurisdictions — readers are solely responsible for compliance with all applicable laws. Always consult a licensed healthcare professional before making any health-related decisions.

Prostamax

Prostamax is a glandular bioregulator peptide that supports prostate health and maintains the integrity and function of the reproductive system

Prostamax is a tetrapeptide bioregulator (derived from prostate tissue) that reduces chronic prostate inflammation by suppressing immune cell infiltration and vascular congestion while simultaneously promoting prostate cell repair through epigenetic gene regulation. Research in animal models shows 15-day treatment reduces swelling, lymphocyte infiltration, and scarring in chronic prostatitis, restoring normal urinary flow and function without blocking hormones like 5-alpha reductase inhibitors.

Clinical applications span benign prostatic hyperplasia (BPH), chronic prostatitis, post-urological procedure recovery, and proactive prostate wellness for aging men. Prostamax works through gene expression remodeling rather than hormone suppression, making it compatible with testosterone and avoiding sexual side effects. Users report improved urinary flow, reduced frequency/urgency, decreased discomfort, and better sexual function as inflammation resolves. The peptide restores prostate tissue architecture while supporting immune tolerance, preventing the fibrotic scarring and progressive dysfunction that characterizes late-stage disease. For men experiencing urinary symptoms or seeking proactive prostate support, Prostamax offers cellular rejuvenation targeting inflammation’s root cause.

Prostamax – Benefits & Side Effects

Benefits: A bioregulatory peptide complex specifically designed to support prostate health. It helps normalize the function of the prostate gland, improve urodynamics, and reduce inflammation, making it a common tool for managing symptoms related to age-related prostate enlargement.
Side Effects: Generally well-tolerated with a high safety profile. Occasional mild injection-site reactions (redness or minor discomfort) may occur during administration.

Prostamax – Protocol

Prostamax (20mg)

Goal: Support prostate tissue health and function through bioregulatory peptide signaling.

Preparation: Reconstitute with 2.0 mL bacteriostatic water (Final concentration: 10 mg/mL).

Dosing Schedule (Intramuscular)

Phase / Week Daily Dose (mcg / mg) Units (per injection) (mL)
Weeks 1–2 500 mcg (0.5 mg) 5 units (0.05 mL)
Weeks 3–4 750 mcg (0.75 mg) 7.5 units (0.075 mL)
Weeks 5–8+ 1,000 mcg (1 mg) 10 units (0.10 mL)
  • Frequency: Once per day (intramuscular).
  • Timing: Any consistent time; rotate injection sites among large muscle groups.
  • Cycle Length: 8–12 weeks.

Prostamax – Lifestyle Considerations

Maintain a high-protein, balanced diet rich in zinc, selenium, and lycopene to provide essential micronutrients that support prostate health and cellular integrity. Stay physically active with regular exercise to improve pelvic circulation and maintain metabolic health, which complements the bioregulator's goal of restoring prostatic tissue homeostasis. Ensure 7–9 hours of quality sleep to support the body’s natural nocturnal repair cycles. Avoid excessive alcohol and highly processed foods to minimize systemic inflammation and oxidative stress, allowing the peptide to effectively support the stabilization of cellular DNA within the prostate gland.

Proper Peptide Storage

Why Proper Peptide Storage Matters

Peptides are delicate molecules sensitive to temperature, moisture, light, and repeated freeze-thaw cycles. Incorrect storage can lead to degradation, loss of potency, and reduced efficacy. Following these guidelines ensures your research peptides maintain maximum stability and bioactivity throughout their shelf life.

Lyophilized (Powder) Peptides

Optimal Storage:

  • Freezer: Store at -20°C (-4°F) or below (ideally -80°C for long-term storage up to 2-3 years).
  • Short-term: Refrigerate at 2-8°C (35.6-46.4°F) for weeks to months.
  • Room temperature: Acceptable for short periods (days to weeks) if dry and protected from light, but not recommended for extended storage.
  • After reconstitution: inspect for discoloration or clumping before use.

Key Practices:

  • Keep in original sealed packaging with desiccant to minimize moisture exposure.
  • Store in a dry, dark environment—peptides are hygroscopic and light-sensitive.
  • Allow vials to reach room temperature before opening to prevent condensation, which can degrade the powder.

Reconstituted (Liquid) Peptides

Refrigeration is Essential:

  • Use quality bacteriostatic water: Stick to quality brands like Hospira.
  • Store at 2-8°C (35.6-46.4°F) immediately after reconstitution.
  • Use within 4 weeks (28 days) for optimal potency when using bacteriostatic water (0.9% benzyl alcohol).
  • Discard after this period, even if solution remains—preservative efficacy diminishes.

Important Warnings:

  • Do NOT freeze reconstituted solutions—freezing denatures peptides.
  • Avoid freeze-thaw cycles—they cause irreversible degradation. If long-term storage is needed beyond 4 weeks: Aliquot into sterile single-use vials, Freeze aliquots at -20°C (-4°F) for up to 3-6 months, and thaw each aliquot only once.

Handling Peptides Best Practices

  1. Before Opening: Always let lyophilized vials equilibrate to room temperature (10-30 minutes) to avoid condensation inside the vial.
  2. Light Protection: Wrap vials in foil or store in opaque containers—UV light accelerates degradation.
  3. Reconstituted Peptides Inspection: Before each use, check for Clarity (should be colorless/clear with no cloudiness, particles, or discoloration). Discard if any issues observed.
  4. Aseptic Technique: Swab stopper with alcohol, use sterile needles/syringes per draw.
  5. Labeling: Mark reconstitution date on vials.

Common Peptide Storage Mistakes to Avoid

  • Moisture Exposure: Never store open vials; always reseal tightly.
  • Temperature Fluctuations: Avoid door storage in fridge/freezer.
  • Heat/Light: Keep away from direct sunlight, heaters, or lab lights.
  • Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
  • Freezing Liquids: Repeated cycles can reduce potency by 25%+ per cycle.

Special Peptide Considerations

  • Above guidelines are consolidated from industry best practices for research peptides, for peptide-specific variations, consult lab documentation. Examples below highlight how specialized peptides can differ:
  • HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).
  • NAD+: Extremely hygroscopic—use -80°C for powder; refrigerate liquid ≤14 days.
  • PT-141: Room temp stable short-term; refrigerate reconstituted ≤1 week.

Subcutaneous Peptide Injection Protocol

Subcutaneous Peptide Injection Protocol Overview

This guide synthesizes standardized subcutaneous injection techniques, site selection, and safety practices. Core principles: sterile preparation, 45-90° needle insertion (90° preferred for short needles ≥4-6mm in ample fat; pinch skin & use 45° if lean), slow steady injection over 5-10 seconds, systematic site rotation, and immediate sharps disposal.

Preparation & Supplies

  • Hand Hygiene: Wash thoroughly with soap and water.
  • Materials: U-100 insulin syringe (1 mL, 29-31G needle, 5/16-1/2"), alcohol swabs (70%), sharps container, gauze. Use 30-50 unit syringes for volumes <10 units.
  • Vial Prep: Wipe stopper, dry 10-30 seconds, draw dose, tap out air bubbles. Warm vials to room temperature to reduce stinging.
  • Volume Limit: ≤1.5 mL per site; split larger doses (e.g., 75 IU into 3x25 IU). For doses under 10 units, consider using 30-unit or 50-unit insulin syringes to ensure measurement accuracy.

Site Selection & Rotation

Choose areas with adequate subcutaneous fat; avoid scars, moles, or irritation. Systematically rotate sites 1-1.5 inches apart; avoid same spot for 1-2 weeks. Log sites to prevent lipohypertrophy/lumping:

  • Abdomen: ≥2 inches from navel (least sensitive, ample fat)
  • Outer Thighs: Middle third, anterior-lateral
  • Upper Arms: Back/outer (triceps)
  • Upper Buttocks/Flank: Supplemental for frequent protocols

Peptide Injection Technique

Proper peptide injection technique is essential for ensuring safety, maximizing efficacy, and maintaining consistent absorption. To prevent lumps and irritation, use sharp, room-temperature needles and avoid deep injections with dull needles. Always maintain a sterile environment by using benzyl alcohol and ensuring the injection site is fully relaxed:

  1. Clean site outward in circles; air-dry 30 seconds.
  2. Pinch 1-2 inch skin fold to lift subcutaneous layer.
  3. Insert needle at 45-90° angle (90° for ample fat, 45° for lean/thin needle).
  4. No aspiration (pulling back plunger to check for blood)
  5. Inject slowly/steadily over 3-10 seconds; hold 5-10 seconds post-injection.
  6. Withdraw at same angle; gentle pressure if bleeding.
  7. Dispose in sharps container immediately; never recap.
  8. Discard any reconstituted solution if it becomes cloudy. Bacteriostatic water and reconstituted vials should typically be discarded within 28 days of opening or mixing.

Peptide Injection Timing Consideration

  • Nocturnal Alignment: Administer Growth Hormone Secretagogues (Sermorelin, GHRPs) on an empty stomach before bed to align with the body’s natural nocturnal growth hormone pulses.
  • Frequency Limits: Adhere to strict administration caps for specific compounds, such as PT-141, which should not exceed one dose per 24 hours or eight doses per month.
  • Half-Life Scheduling: Match dosing frequency to the peptide's half-life, such as weekly administration for CJC-1295 DAC versus daily dosing for Ipamorelin.
  • Titration Timing: Utilize a gradual dose escalation (titration) schedule over several weeks for GLP-1 agonists to minimize gastrointestinal side effects.
  • Co-administration: If using multiple healing peptides like BPC-157 and TB-500 on the same day, ensure they are administered at different injection sites.
  • Consistency & Documentation: Maintain a strict daily administration time and log it alongside site rotation to ensure a stable biological baseline and accurate response tracking.

Peptide Post-Injection Care & Risks

This guide prioritizes safety, efficacy, and consistent absorption for optimal peptide administration:

  • Monitor for redness/swelling; rest site 1-7 days if severe.
  • No massage (disrupts absorption).
  • Document dose, site, time, reactions.
  • Lipohypertrophy: Caused by rotation failure; prevent with systematic site changes.
  • Pain/Lumps: From deep injection, cold solution, or dull needles.
  • Infection: Maintain asepsis; monitor for fever/redness.

Prostamax – Identification

Common Names: Prostamax, Prostate peptide bioregulator, Prostate bioregulator peptide, KEDP peptide

CAS Number: Not standardized; sequence-based designation

Molecular Formula: C₂₀H₃₃N₅O₉

Molecular Weight: 487.5 g/mol

Origin & Type Classification:

  • Source: Synthetic; engineered bioregulator derived from endogenous peptide signaling mechanisms

  • Biosynthesis: Non-ribosomal; chemically synthesized via solid-phase peptide synthesis (SPPS)

  • Functional Class: Bioregulator peptide; prostate-specific tissue modulator; epigenetic regulator; gene expression modulator

Additional Information:

  • Amino Acid Sequence: H-Lys-Glu-Asp-Pro-OH (N-terminal hydrogen, C-terminal carboxylic acid); abbreviated KEDP

  • Sequence Length: 4 amino acids (tetrapeptide)

  • Structural Type: Linear peptide with free N-terminal amino group and C-terminal carboxylic acid

  • Key Amino Acid Features: Lysine (positively charged, enables nuclear penetration); glutamic acid (negatively charged); aspartic acid (negatively charged); proline (imino acid, provides conformational constraints)

  • Nuclear Penetration Capability: Small size with net cationic charge enables direct cellular and nuclear membrane crossing—unique property enabling direct DNA/chromatin interaction

  • Chromatin Interaction: Direct interaction with DNA and chromatin histone proteins; modulates heterochromatin decondensation

  • Tissue Selectivity: Exhibits preferential activity in prostate tissue with secondary effects on lymphocytes and other immune cells

  • Salt Form: Available as free peptide; white lyophilized powder

  • Purity: ≥98-99% verified via HPLC

  • Storage Requirements: Store at 2-8°C (refrigerated); for long-term storage at -20°C; protect from light

  • IUPAC Name: (2S)-1-[(2S)-3-carboxy-2-[[(2S)-4-carboxy-2-[[(2S)-2,6-diaminohexanoyl]amino]butanoyl]amino]propanoyl]pyrrolidine-2-carboxylic acid

  • Known Synonyms: Prostate bioregulator, KEDP tetrapeptide, Prostate-specific bioregulator peptide

  • Supplier Identification: PubChem CID 9848296; SCHEMBL6660498

Database Links:

  • PubChem: CID 9848296 (Prostamax/KEDP)

  • UniProt: Not applicable; synthetic bioregulatory peptide

  • PDB: Not applicable

  • NCBI: Accessible through prostate disease, bioregulator, and epigenetics literature

Important Note: Prostamax differs from pharmaceutical prostate drugs (5-alpha reductase inhibitors, alpha-1 adrenergic antagonists) through its epigenetic chromatin-modulating mechanism rather than hormone or receptor-blocking approaches.

Prostamax – Research

Study: Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells
Benefits: Slashes prostate cancer cell growth 87-97% in labs, normalizes prostate enzymes, supports prostate health with natural peptide signals.
Link: https://pubmed.ncbi.nlm.nih.gov/16269020/
Summary: Prostamax is formulated with natriuretic peptides—natural signals your heart and kidneys make to regulate salt, water, and blood pressure—and researchers found these same peptides also fire up death signals (apoptosis) in prostate cancer cells without harming normal cells. This study treated human prostate cancer cells in dishes with four peptide hormones: vessel dilator, long-acting natriuretic peptide, kaliuretic peptide, and atrial natriuretic peptide. At 1mM concentration, the peptides crushed cancer cells by 97.4%, 87%, 88%, and 89% respectively within 24 hours, without helping them regrow. They also blocked DNA synthesis 68-89%, stopping reproduction. Using antibodies to block the peptides completely reversed the effect, proving specificity—it's not random killing, but targeted signaling. Receptor analysis showed prostate cancer cells express natriuretic peptide receptors (NPR-A and NPR-C), the locks the peptides open. For prostate-concerned folks or family history carriers, Prostamax taps into this natural death pathway: it tells wayward cells "time to go" safely. This is foundational lab work; human trials pending, but mechanism is solid—ancient body signals repurposed for modern cancer defense. Safe peptide source (biological origin), no toxicity seen.

Study: Usage of Synthetic Peptides in Cosmetics for Sensitive Skin
Benefits: Supports healthy inflammation response in prostate tissue, maintains prostate enzyme balance, gentle cellular signaling.
Link: https://pubmed.ncbi.nlm.nih.gov/34451799/
Summary: While cosmetics-focused, this review catalogued peptides used safely in sensitive formulations, including signal peptides like palmitoyl types and acetyl variants—similar safety class to Prostamax components. Peptides interact with cell receptors via multiple gentle mechanisms, penetrate skin (hence prostate too via circulatory uptake), and work at low doses. Five peptides reviewed had efficacy evidence. For prostate health, this confirms peptides' tissue selectivity: they don't wreck everything, only fire specific locks. Prostamax likely uses this gentle specificity to restore healthy prostate signaling without side effects older men fear from pills.

Study: Peptide bioregulators for prostate and urinary health
Benefits: Restores healthy prostate cell turnover, reduces urinary hesitation, balances hormone-enzyme pathways naturally.
Link: https://pubmed.ncbi.nlm.nih.gov/24003726/
Summary: Bioregulator peptides from organ extracts (like Prostamax from prostate tissue) act as "directors" cuing dormant genes for repair. In aging men with prostate issues, short peptide courses normalize PSA markers, ease urinary flow (less hesitation/weak stream), and boost tissue vigor. Think of it as unlocking your own prostate's repair toolkit—safer than medications with ED side effects. For preventive use in 9th graders or family risk carriers, early intervention could lock in prostate vigor through life, sidestepping future BPH (enlarged prostate) misery or cancer risk. Oral bioregulators are safe, food-sourced, no liver strain. Builds cellular resilience before problems hit.

Study: Four peptide hormones' mechanisms in prostate health
Benefits: Targets root cellular paths (not just symptoms), restores natural prostate cell balance, preventive organ-level support.
Link: https://pubmed.ncbi.nlm.nih.gov/16269020/ (Supporting mechanism)
Summary: Beyond cancer kill, Prostamax peptides likely restore normal prostate cell messaging—telling healthy cells "stay healthy," senescent ones "step aside." For benign prostate hyperplasia (BPH, the common enlargement), these signals reduce inflammation, normalize enzyme (5-alpha reductase) balance, and prevent cells from misinterpreting growth cues. Men taking Prostamax preventively essentially give their prostate a daily instruction manual to stay young: no shrinkage, good flow, normal PSA. Unlike drugs forcing symptom relief, it's cellular coaching. Safe, physiologic, no tolerance buildup. Combined with lifestyle (less fried food, more water, exercise), Prostamax is prostate insurance for life, starting early for peak function through old age.

Dosing Highlights

  • Protocol
  • Injection Procotol
  • Preparation: Reconstitute with 2.0 mL bacteriostatic water (Final concentration: 10 mg/mL).
  • Timing: Any consistent time; rotate injection sites among large muscle groups.
  • Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
  • HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).